Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology

Nucleic Acid Therapeutics

Volumn 22, Issue 4, 2012, Pages 226-245

  Guo, Peixuan ^a   Haque, Farzin ^a   Hallahan, Brent ^a   Reif, Randall ^a   Li, Hui ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; COMPLEMENTARY RNA; MICRORNA; MICROSPHERE; NANOPARTICLE; PACKAGING RNA; RIBOZYME; RNA; RNA INDUCED SILENCING COMPLEX; RNA NANOPARTICLE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CANCER CELL; COST BENEFIT ANALYSIS; DRUG DISTRIBUTION; DRUG HALF LIFE; ENDOCYTOSIS; ENDOSOME; ENDOSOME TRAPPING; GENE DELIVERY SYSTEM; GENE TARGETING; HUMAN; IMMUNOTOXICITY; IN VIVO STUDY; NANOTECHNOLOGY; NONHUMAN; PERMEABILITY; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; REVIEW; RIBOSWITCH; RNA FOLDING; RNA INTERFERENCE; RNA NANOTECHNOLOGY; RNA STRUCTURE; RNA TRANSCRIPTION; STOICHIOMETRY; THERMODYNAMICS; THERMOSTABILITY;

EID: 84865436732     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0350     Document Type: Review

References (173)

1. ABDELMAWLA, S., GUO S., ZHANG, L., PULUKURI, S., PATANKAR P., CONLEY, P., TREBLEY, J., GUO, P., and LI, Q.X. (2011). Pharmacological characterization of chemically synthesized monomeric pRNA nanoparticles for systemic delivery. Mol. Ther. 19, 1312-1322.
2. AFONIN, K.A., BINDEWALD, E., YAGHOUBIAN, A.J., VOSS, N., JACOVETTY, E., SHAPIRO, B.A., and JAEGER, L. (2010). In vitro assembly of cubic RNA-based scaffolds designed in silico. Nat. Nanotechnol. 5, 676-682.
3. AFONIN, K.A., GRABOW, W.W., WALKER, F.M., BINDEWALD, E., DOBROVOLSKAIA, M.A., SHAPIRO, B.A., and JAEGER, L. (2011). Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat. Protoc. 6, 2022-2034.
4. BADER, A.G., BROWN, D., and WINKLER, M. (2010). The promise of microRNA replacement therapy. Cancer Res. 70, 7027-7030.
5. BANTA, S., MEGEED, Z., CASALI, M., REGE, K., and YARMUSH, M.L. (2007). Engineering protein and peptide building blocks for nanotechnology. J. Nanosci. Nanotechnol. 7, 387-401.
6. BARRICK, J.E., and BREAKER, R.R. (2007). The distributions, mechanisms, and structures of metabolite-binding riboswitches. Genome Biol. 8, R239.
7. BARTEL, D.P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
8. BARTZ, R., FAN, H., ZHANG, J., INNOCENT, N., CHERRIN, C., BECK, S.C., PEI, Y., MOMOSE, A., JADHAV, V., TELLERS, D.M., MENG, F., CROCKER, L.S., SEPP-LORENZINO, L., and BARNETT, S.F. (2011). Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Biochem. J. 435, 475-487.
9. BEHLKE, M.A. (2006). Progress towards in vivo use of siRNAs. Mol. Ther. 13, 644-670.
10. BINDEWALD, E., AFONIN, K., JAEGER, L., and SHAPIRO, B.A. (2011). Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots. ACS Nano. 5, 9542-9551.
11. BINDEWALD E, GRUNEWALD C, BOYLE B, O'CONNOR M, and SHAPIRO BA (2008a). Computational strategies for the automated design of RNA nanoscale structures from building blocks using NanoTiler. J. Mol. Graph. Model. 27, 299-308.
12. BINDEWALD, E., HAYES, R., YINGLING, Y.G., KASPRZAK, W., and SHAPIRO, B.A. (2008b). RNAJunction: a database of RNA junctions and kissing loops for three-dimensional structural analysis and nanodesign. Nucleic Acids Res. 36, D392-D397. (Pubitemid 351149755)
13. BREAKER, R.R. (2012). Riboswitches and the RNA world. Cold Spring Harb. Perspect. Biol. 4.
14. BREAKER, R.R. (2008). Complex riboswitches. Science 319, 1795-1797. (Pubitemid 351451558)
15. BRUMMELKAMP, T.R., BERNARDS, R., and AGAMI, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553. (Pubitemid 34408678)
16. CARMICHAEL, G.G. (2002). Medicine: silencing viruses with RNA. Nature 418, 379-380.
17. CAYROL, B., NOGUES, C., DAWID, A., SAGI, I., SILBERZAN, P., and ISAMBERT, H. (2009). A nanostructure made of a bacterial noncoding RNA. J. Am. Chem. Soc. 131, 17270-17276.
18. CHANG, C.I., LEE, T.Y., KIM, S., SUN, X., HONG, S.W., YOO, J.W., DUA, P., KANG, H.S., KIM, S., LI, C.J., and LEE, D.K. (2012A). Enhanced intracellular delivery and multi-target gene silencing triggered by tripodal RNA structures. J. Gene Med. 14, 138-146.
19. CHANG, C.I., LEE, T.Y., YOO, J.W., SHIN, D., KIM, M., KIM, S., and LEE, D.K. (2012B). Branched, tripartite-interfering RNAs silence multiple target genes with long guide strands. Nucleic Acid Ther. 22, 30-39.
20. CHANG, K.Y. and TINOCO, I., JR. (1994). Characterization of a ''kissing'' hairpin complex derived from the human immunodeficiency virus genome. Proc. Natl. Acad. Sci. U. S. A. 91, 8705-8709.
21. CHEAH, M.T., WACHTER, A., SUDARSAN, N., and BREAKER, R.R. (2007). Control of alternative RNA splicing and gene expression by eukaryotic riboswitches. Nature 447, 497-500. (Pubitemid 46816734)
22. CHEN, C., SHENG, S., SHAO, Z., and GUO, P. (2000). A dimmer as a building block in assembling RNA: A hexamer that gears bacterial virus phi29 DNA-translocating machinery. J. Biol. Chem. 275, 17510-17516. (Pubitemid 30430792)
23. CHEN, C., ZHANG, C., and GUO, P. (1999). Sequence requirement for hand-in-hand interaction in formation of pRNA dimers and hexamers to gear phi29 DNA translocation motor. RNA 5, 805-818. (Pubitemid 29283782)
24. CHEN, J.F., MURCHISON, E.P., TANG, R., CALLIS, T.E., TATSUGUCHI, M., DENG, Z., ROJAS, M., HAMMOND, S.M., SCHNEIDER, M.D., SELZMAN, C.H., MEISSNER, G., PATTERSON, C., HANNON, G.J., and WANG, D.Z. (2008). Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. U. S. A. 105, 2111-2116. (Pubitemid 351439473)
25. CHOWRIRA, B.M., BERZAL-HERRANZ, A., and BURKE, J.M. (1991). Novel guanosine requirement for catalysis by the hairpin ribozyme. Nature 354, 320-322. (Pubitemid 21896887)
26. CHWOROS, A., SEVERCAN, I., KOYFMAN, A.Y., WEINKAM, P., OROUDJEV, E., HANSMA, H.G., and JAEGER, L. (2004). Building programmable jigsaw puzzles with RNA. Science306, 2068-2072. (Pubitemid 40007653)
27. CLEVER, J.L., WONG, M.L., and PARSLOW, T.G. (1996). Requirements for kissing-loop-mediated dimerization of human immunodeficency virus RNA. J. Virol. 70, 5902-8. (Pubitemid 26266802)
28. COLEMAN, J., HIRASHIMA, A., INOCUCHI, Y., GREEN, P.J., and INOUYE, M. (1985). A novel immune system against bacteriophage infection using complementary RNA (micRNA). Nature 315, 601-603. (Pubitemid 15021203)
29. COTTEN, M., WAGNER, E., ZATLOUKAL, K., PHILLIPS, S., CURIEL, D.T., and BIRNSTIEL, M.L. (1992). High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. U. S. A. 89, 6094-6098.
30. DASSIE, J.P., LIU, X.Y., THOMAS, G.S., WHITAKER, R.M., THIEL, K.W., STOCKDALE, K.R., MEYERHOLZ, D.K., MCCAFFREY, A.P., MCNAMARA, J.O., and GIANGRANDE, P.H. (2009). Systemic administration of optimized aptamersiRNA chimeras promotes regression of PSMA-expressing tumors. Nat. Biotechnol. 27, 839-849.
31. DE FOUGEROLLES, A., VORNLOCHER, H.P., MARAGANORE, J., and LIEBERMAN, J. (2007). Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Discov. 6, 443-453. (Pubitemid 47064567)
32. DELEBECQUE, C.J., LINDNER, A.B., SILVER, P.A., and ALDAYE, F.A. (2011). Organization of intracellular reactions with rationally designed RNA assemblies. Science 333, 470-474.
33. DIBROV, S.M., MCLEAN, J., PARSONS, J., and HERMANN, T. (2011). Self-assembling RNA square. Proc. Natl. Acad. Sci. U. S. A. 108, 6405-6408.
34. DOERMANN, A.H. (1973). T4 and the rolling circle model of replication. Annu. Rev. Genet. 7, 325-341.
35. DUNCAN, R. (2011). Polymer therapeutics as nanomedicines: new perspectives. Curr. Opin. Biotechnol. 22, 492-501.
36. EDITORIAL COMMENT (2011). The story so far: basic research in nanoscience and technology is flourishing, but obstacles to real-world applications remain. Nat. Nanotechnol. 6, 603.
37. EHRESMANN, C., BAUDIN, F., MOUGEL, M., ROMBY, P., EBEL, J-P., and EHRESMANN, B. (1987). Probing the structure of RNAs in solution. Nucleic Acids Res. 15, 9109-9128.
38. ELLINGTON, A.D. and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
39. FENG, Y., KONG, Y.Y., WANG, Y., and QI, G.R. (2001). Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells. Biol, Chem. 382, 655-660. (Pubitemid 32472176)
40. FIRE, A., XU, S., MONTGOMERY, M.K., KOSTAS, S.A., DRIVER, S.E., and MELLO, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. (Pubitemid 28099681)
41. FORSTER, A.C., and SYMONS, R.H. (1987). Self-cleavage of virusoid RNA is performed by the proposed 55-nucleotide active site. Cell 50, 9-16.
42. FREIER, S.M., KIERZEK, R., JAEGER, J.A., SUGIMOTO, N., CARUTHERS, M.H., NEILSON, T., and TURNER, D.H. (1986). Improved free-energy parameters for predictions of RNA duplex stability. Proc. Natl. Acad. Sci. U. S. A. 83, 9373-9377. (Pubitemid 17223363)
43. GAO, H., SHI, W., and FREUND, L.B. (2005). Mechanics of receptor- mediated endocytosis. Proc. Natl. Acad. Sci. U. S. A. 102, 9469-9474.
44. GEARY, C., CHWOROS, A., and JAEGER, L. (2010). Promoting RNA helical stacking via A-minor junctions. Nucleic Acids Res. 39, 1066-1080.
45. GRABOW, W.W., ZAKREVSKY, P., AFONIN, K.A., CHWOROS, A., SHAPIRO, B.A., and JAEGER, L. (2011). Selfassembling RNA nanorings based on RNAI/II inverse kissing complexes. Nano Lett. 11, 878-887.
46. GUERRIER-TAKADA, C., GARDINER, K., MARSH, T., PACE, N., and ALTMAN, S. (1983). The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857. (Pubitemid 14168384)
47. GUO, P. (2005). RNA nanotechnology: engineering, assembly, and applications in detection, gene delivery and therapy. J. Nanosci. Nanotech 5, 1964-1982. (Pubitemid 44874820)
48. GUO, P. (2010). The emerging field of RNA nanotechnology. Nat. Nanotechnol. 5, 833-842.
49. GUO, P., COBAN, O., SNEAD, N.M., TREBLEY, J., HOEPRICH, S., GUO, S., and SHU, Y. (2010). Engineering RNA for targeted siRNA delivery and medical application. Adv. Drug Deliv. Rev. 62, 650-666.
50. GUO, P., ERICKSON, S., and ANDERSON, D. (1987). A small viral RNA is required for in vitro packaging of bacteriophage phi29 DNA. Science 236, 690-694. (Pubitemid 17076855)
51. GUO, P., ZHANG, C., CHEN, C., TROTTIER, M., and GARVER, K. (1998). Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. Mol. Cell 2, 149-155. (Pubitemid 128378977)
52. GUO, S., TSCHAMMER, N., MOHAMMED, S., and GUO, P. (2005). Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. Hum. Gene Ther. 16, 1097-1109. (Pubitemid 41324569)
53. GUO, S., HUANG, F., and GUO, P. (2006). Construction of folate- conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells. Gene Ther. 13, 814-820.
54. GYI, J.I., CONN, G.L., LANE, A.N., and BROWN, T. (1996). Comparison of the thermodynamic stabilities and solution conformations of DNA center dot RNA hybrids containing purine-rich and pyrimidine-rich strands with DNA and RNA duplexes. Biochemistry 35, 12538-12548. (Pubitemid 26318051)
55. HAMILTON, A.J., and BAULCOMBE, D.C. (1999). A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286, 950-952.
56. HAQUE, F., SHU, D., SHU, Y., SHLYAKHTENKO, L., RYCHAHOU, P., EVERS, M., and GUO, P. (2012). Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today DOI: 10.1016/j.nantod.2012.06.010. 2012.
57. HE, L., and HANNON, G.J. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531. (Pubitemid 38868508)
58. HENDRIX, R.W. (1998). Bacteriophage DNA packaging: RNA gears in a DNA transport machine (Minireview). Cell 94, 147-150. (Pubitemid 28348001)
59. HENKIN, T.M. (2008). Riboswitch RNAs: using RNA to sense cellular metabolism. Genes Dev. 22, 3383-3390.
60. HOEPRICH, S., ZHOU, Q., GUO, S., QI, G., WANG, Y., and GUO, P. (2003). Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus. Gene Ther. 10, 1258-1267. (Pubitemid 36934728)
61. HONG, J., HUANG, Y., LI, J., YI, F., ZHENG, J., HUANG, H., WEI, N., SHAN, Y., AN, M., ZHANG, H., JI, J., ZHANG, P., XI, Z., DU, Q., and LIANG, Z. (2010). Comprehensive analysis of sequence-specific stability of siRNA. FASEB J. 24, 4844-4855.
62. IKAWA, Y., TSUDA, K., MATSUMURA, S., and INOUE, T. (2004). De novo synthesis and development of an RNA enzyme. Proc. Natl. Acad. Sci. U. S. A. 101, 13750-13755. (Pubitemid 39298479)
63. ISAMBERT, H. (2009). The jerky and knotty dynamics of RNA. Methods 49, 189-196.
64. JACQUE, J.M., TRIQUES, K., and STEVENSON, M. (2002). Modulation of HIV-1 replication by RNA interference. Nature 418, 435-438. (Pubitemid 34826845)
65. JAEGER, L., and CHWOROS, A. (2006). The architectonics of programmable RNA and DNA nanostructures. Curr. Opin. Struct. Biol. 16, 531-543. (Pubitemid 44149075)
66. JAEGER, L. and LEONTIS, N.B. (2000). Tecto-RNA: one dimensional self-assembly through tertiary interactions. Angew Chem. Int. Ed. Engl. 39, 2521-2524. (Pubitemid 30602533)
67. JAEGER, L., WESTHOF, E., and LEONTIS, N.B. (2001). TectoRNA: modular assembly units for the construction of RNA nano-objects. Nucleic Acids Res. 29, 455-463. (Pubitemid 32060932)
68. JAIN, K.K. (2005). The role of nanobiotechnology in drug discovery. Drug Discov. Today 10, 1435-1442. (Pubitemid 41483872)
69. JOSSINET, F., LUDWIG, T.E., and WESTHOF, E. (2007). RNA structure: bioinformatic analysis. Curr. Opin. Microbiol. 10, 279-285. (Pubitemid 46963087)
70. KASINSKI, A.L., and SLACK, F.J. (2011). Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 11, 849-864.
71. KASPRZAK, W., BINDEWALD, E., KIM, T.J., JAEGER, L., and SHAPIRO, B.A. (2010). Use of RNA structure flexibility data in nanostructure modeling. Methods 54, 239-250.
72. KHALED, A., GUO, S., LI, F., and GUO, P. (2005). Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Lett. 5, 1797-1808. (Pubitemid 41396168)
73. KIM, D.H., and ROSSI, J.J. (2007). Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8, 173-184.
74. KNECHT, D.A., and LOOMIS, W.F. (1987). Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum. Science 236, 1081-1086. (Pubitemid 17113249)
75. KRUGER, K., GRABOWSKI, P.J., ZAUG, A.J., SANDS, J., GOTTSCHLING, D.E., and CECH, T.R. (1982). Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31, 147-157. (Pubitemid 13215202)
76. KWON, Y.J. (2011). Before and after endosomal escape: roles of stimuli-converting siRNA/Polymer interactions in determining gene silencing efficiency. Acc. Chem. Res. 45, 1077-1088.
77. LAING, C., and SCHLICK, T. (2010). Computational approaches to 3D modeling of RNA. J. Phys. Condens. Matter 22, 283101.
78. LANGLET-BERTIN, B., LEBORGNE, C., SCHERMAN, D., BECHINGER, B., MASON, A.J., and KICHLER, A. (2010). Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery. Pharm. Res. 27, 1426-1436.
79. LAURENTI, E., BARDE, I., VERP, S., OFFNER, S., WILSON, A., QUENNEVILLE, S., WIZNEROWICZ, M., MACDONALD, H.R., TRONO, D., and TRUMPP, A. (2010). Inducible gene and shRNA expression in resident hematopoietic stem cells in vivo. Stem Cells 28, 1390-1398.
80. LEE, J.B., HONG, J., BONNER, D.K., POON, Z., and HAMMOND, P.T. (2012). Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat. Mater. 11, 316-322.
81. LEONTIS, N.B., LESCOUTE, A., and WESTHOF, E. (2006). The building blocks and motifs of RNA architecture. Curr. Opin. Struct. Biol. 16, 279-287. (Pubitemid 43831653)
82. LEONTIS, N.B., and WESTHOF, E. (2003). Analysis of RNA motifs. Curr. Opin. Struct. Biol. 13, 300-308. (Pubitemid 36782455)
83. LESCOUTE, A., and WESTHOF, E. (2006). Topology of threeway junctions in folded RNAs. RNA 12, 83-93. (Pubitemid 43037456)
84. LESNIK, E.A., and FREIER, S.M. (1995). Relative thermodynamic stability of DNA, RNA, and DNA-RNA hybrid duplexes: relationship with base composition and structure. Biochemistry 34, 10807-10815.
85. LI, H., LI, W.X., and DING, S.W. (2002). Induction and suppression of RNA silencing by an animal virus. Science 296, 1319-1321. (Pubitemid 34522787)
86. LI, W., and SZOKA, F. (2007). Lipid-based nanoparticles for nucleic acid delivery. Pharm Res, 24, 438-449.
87. LI, X., HORIYA, S., and HARADA, K. (2006). An efficient thermally induced RNA conformational switch as a framework for the functionalization of RNA nanostructures. J. Am. Chem. Soc., 128, 4035-4040.
88. LILLEY, D.M. (1999). Structure, folding, and catalysis of the small nucleolytic ribozymes. Curr. Opin. Struct. Biol. 9, 330-338. (Pubitemid 29454500)
89. LIM, Y.B., KIM, S.M., SUH, H., and PARK, J.S. (2002). Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjug. Chem. 13, 952-957.
90. LIU, J., GUO, S., CINIER, M., SHLYAKHTENKO, L., SHU, Y., CHEN, C., SHEN, G., and GUO, P. (2010). Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging. ACS Nano. 5, 237-246.
91. LIU, H., GUO, S., ROLL, R., LI, J., DIAO, Z., SHAO, N., RILEY, M.R., COLE, A.M., ROBINSON, J.P., SNEAD, N.M., SHEN, G., and GUO, P. (2007). Phi29 pRNA vector for efficient escort of hammerhead ribozyme targeting survivin in multiple cancer cells. Cancer Biol. Ther. 6, 697-704. (Pubitemid 47328350)
92. MADHURI, V., and KUMAR, V.A. (2010). Design, synthesis, and DNA/RNA binding studies of nucleic acids comprising stereoregular and acyclic polycarbamate backbone: polycarbamate nucleic acids (PCNA). Org. Biomol. Chem. 8, 3734-3741.
93. MAES, O.C., CHERTKOW, H.M., WANG, E., and SCHIPPER, H.M. (2009). MicroRNA: Implications for Alzheimer disease and other human CNS disorders. Curr Genomics, 10, 154-168.
94. MARSHALL, W.S., and KAISER, R.J. (2004). Recent advances in the high-speed solid phase synthesis of RNA. Curr. Opin. Chem. Biol. 8, 222-229. (Pubitemid 38759396)
95. MASTROBATTISTA, E., KONING, G.A., VAN BLOOIS, L., FILIPE, A.C., JISKOOT, W., and STORM, G. (2002). Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J. Biol. Chem. 277, 27135-27143. (Pubitemid 34951728)
96. MATHE, C., and PERIGAUD, C. (2008). Recent approaches in the synthesis of conformationally restricted nucleoside analogues. European J. Org. Chem. 2008, 1489-1505.
97. MATHEWS, D.H., and TURNER, D.H. (2006). Prediction of RNA secondary structure by free energy minimization. Curr. Opin. Struct. Biol. 16, 270-278. (Pubitemid 43831654)
98. MATSUMURA, S., OHMORI, R., SAITO, H., IKAWA., Y., and INOUE, T. (2009). Coordinated control of a designed transacting ligase ribozyme by a loop-receptor interaction. FEBS Lett. 583, 2819-2826.
99. MCKINNEY, S.A., DECLAIS, A.C., LILLEY, D.M.J., and HA, T. (2003). Structural dynamics of individual Holliday junctions. Nat. Struct. Biol. 10, 93-97. (Pubitemid 36177087)
100. MCNAMARA, J.O., ANDRECHEK, E.R., WANG, Y., VILES, K.D., REMPEL, R.E., GILBOA, E., SULLENGER, B.A., and GIANGRANDE, P.H. (2006). Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotech. 24, 1005-1015. (Pubitemid 44215395)
101. MI, J., LIU, Y., RABBANI, Z.N., YANG, Z., URBAN, J.H., SULLENGER, B.A., and CLARY, B.M. (2010). In vivo selection of tumor-targeting RNA motifs. Nat. Chem. Biol. 6, 22-24.
102. MIDOUX, P., PICHON, C., YAOUANC, J.J., and JAFFRES, P.A. (2009). Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol, 157, 166-178.
103. MOLL, D., and GUO, P. (2007). Grouping of ferritin and gold nanoparticles conjugated to pRNA of the phage phi29 DNApackaging motor. J. Nanosci. Nanotech. 7, 3257-3267.
104. MOLL, D., HUBER, C., SCHLEGEL, B., PUM, D., SLEYTR, U.B., and SARA, M. (2002). S-layer-streptavidin fusion proteins as template for nanopatterned molecular arrays. Proc. Natl. Acad. Sci. U. S. A. 99, 14646-14651. (Pubitemid 35334538)
105. MORRISSEY, D.V., LOCKRIDGE, J.A., SHAW, L., BLANCHARD, K., JENSEN, K., BREEN, W., HARTSOUGH, K., MACHEMER, L., RADKA, S., ET AL. (2005). Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol, 23, 1002-1007. (Pubitemid 41114035)
106. MUJEEB, A., CLEVER, J.L., BILLECI, T.M., JAMES, T.L., and PARSLOW, T.G. (1998). Structure of the dimer initiation complex of HIV-1 genomic RNA. Nat. Struct. Biol. 5, 432-436. (Pubitemid 28265024)
107. NAKASHIMA, Y., ABE, H., ABE, N., AIKAWA, K., and ITO, Y. (2011). Branched RNA nanostructures for RNA interference. Chem. Commun. (Camb.) 47, 8367-8369.
108. NASALEAN, L., BAUDREY, S., LEONTIS, N.B., and JAEGER, L. (2006). Controlling RNA self-assembly to form filaments. Nucleic Acids Res. 34, 1381-1392.
109. NIMESH, S., GUPTA, N., and CHANDRA, R. (2011). Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids. J. Biomed. Nanotechnol. 7, 504-520.
110. OGAWA, A. and MAEDA, M. (2008). An artificial aptazymebased riboswitch and its cascading system in E. coli. Chembiochem. 9, 206-209. (Pubitemid 351196787)
111. OHNO, H., KOBAYASHI, T., KABATA, R., ENDO, K., IWASA, T., YOSHIMURA, S.H., TAKEYASU, K., INOUE, T., and SAITO, H. (2011). Synthetic RNA-protein complex shaped like an equilateral triangle. Nat. Nanotechnol. 6, 116-120.
112. PANYAM, J., ZHOU, W.Z., PRABHA, S., SAHOO, S.K., and LABHASETWAR, V. (2002). Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 16, 1217-1226. (Pubitemid 34815409)
113. PATRA, A., and RICHERT, C. (2009). High fidelity base pairing at the 3¢-terminus. J. Am. Chem. Soc. 131, 12671-12681.
114. PITSCH, S., WEISS, P.A., JENNY, L., STUTZ, A., and WU, X. (2001). Reliable chemical synthesis of oligoribonucleotides (RNA) with 2¢-O-[(trisisopropylsilyl)oxy]methyl (2¢-O-tom)- protected phosphoramidites. Helv. Chim. Acta 84, 3773-3795.
115. PLANK, C., OBERHAUSER, B., MECHTLER, K., KOCH, C., and WAGNER, E. (1994). The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269, 12918-12924. (Pubitemid 24202092)
116. PLEIJ, C.W., and BOSCH, L. (1989). RNA pseudoknots: structure, detection, and prediction. Meth. Enzymol. 180, 289-303. (Pubitemid 20039581)
117. PLEIJ, C.W.A., RIETVELD, K., and BOSCH, L. (1985). A new principle of RNA folding based on pseudoknotting. Nucleic Acids Res. 13, 1717.
118. PONCHON, L., and DARDEL, F. (2007). Recombinant RNA technology; the tRNA scaffold. Nat. Methods 4, 571-576. (Pubitemid 47214776)
119. PONCHON, L., BEAUVAIS, G., NONIN-LECOMTE, S., and DARDEL, F. (2009). A generic protocol for the expression and purification of recombinant RNA in Escherichia coli using a tRNA scaffold. Nat. Protoc., 4, 947-959.
120. PONCHON, L., and DARDEL, F. (2011). Large scale expression and purification of recombinant RNA in Escherichia coli. Methods 54, 267-273.
121. PRABHA, S., ZHOU, W.Z., PANYAM, J., and LABHASETWAR, V. (2002). Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm. 244, 105-115. (Pubitemid 35245451)
122. PRATS, A.C., ROY, C., WANG, P.A., ERARD, M., HOUSSET, V., GABUS, C., PAOLETTI, C., and DARLIX, J.L. (1990). Cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA. J. Virol. 64, 774-83. (Pubitemid 20032694)
123. PRIVALOV, P.L., and FILIMINOV, V.V. (1978). Thermodynamic analysis of transfer RNA unfolding. J. Mol. Biol. 122, 447-464. (Pubitemid 8401317)
124. RAJAGOPAL, K., and SCHNEIDER, J.P. (2004). Self-assembling peptides and proteins for nanotechnological applications. Curr. Opin. Struct. Biol. 14, 480-486. (Pubitemid 39099286)
125. REESE, C.B. (2002). The chemical synthesis of oligo- and polynucleotides: a personal commentary. Tetrahedron 58, 8893-8920. (Pubitemid 35287443)
126. REID, B.R. (1981). NMR studies on RNA structure and dynamics. Annu. Rev. Biochem. 50, 969-996.
127. REID, R.J.D., ZHANG, F., BENSON, S., and ANDERSON, D. (1994). Probing the structure of bacteriophage phi29 prohead RNA with specific mutations. J. Biol. Chem. 269, 18656-18661. (Pubitemid 24224108)
128. ROZEMA, D.B., LEWIS, D.L., WAKEFIELD, D.H., WONG, S.C., KLEIN, J.J., ROESCH, P.L., BERTIN, S.L., REPPEN, T.W., CHU, Q., ET AL. (2007). Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 104, 12982-12987. (Pubitemid 351737577)
129. SARVER, N.A., CANTIN, E.M., CHANG, P.S., ZAIA, J.A., LADNE, P.A., STEPHENS, D.A., and ROSSI, J.J. (1990). Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225.
130. SCARINGE, S.A., WINCOTT, F.E., and CARUTHERS, M.H. (1998). Novel RNA synthesis method using 5 ¢-O-silyl-2 ¢-Oorthoester protecting groups. J. Am. Chem. Soc. 120, 11820-11821. (Pubitemid 28543605)
131. SCHROEDER, K.T., MCPHEE, S.A., OUELLET, J., and LILLEY, D.M. (2010). A structural database for k-turn motifs in RNA. RNA 16, 1463-1468.
132. SEARLE, M.S., and WILLIAMS, D.H. (1993). On the stability of nucleic acid structures in solution: enthalpy-entropy compensations, internal rotations, and reversibility. Nucleic Acids Res. 21, 2051-2056. (Pubitemid 23160720)
133. SEEMAN, N.C. (2010). Nanomaterials based on DNA. Annu. Rev. Biochem. 79, 65-87.
134. SEVERCAN, I., GEARY, C., CHWOROS, A., VOSS, N., JACOVETTY, E., and JAEGER, L. (2010). A polyhedron made of tRNAs. Nat. Chem. 2, 772-779.
135. SEVERCAN, I., GEARY, C., VERZEMNIEKS, E., CHWOROS, A., and JAEGER, L. (2009). Square-shaped RNA particles from different RNA folds. Nano Lett. 9, 1270-1277.
136. SHAHBABIAN, K., JAMALLI, A., ZIG, L., and PUTZER, H. (2009). RNase Y, a novel endoribonuclease, initiates riboswitch turnover in Bacillus subtilis. EMBO J. 28, 3523-3533.
137. SHAPIRO, B.A., BINDEWALD, E., KASPRZAK, W., and YINGLING, Y. (2008). Protocols for the in silico design of RNA nanostructures. Methods Mol. Biol. 474, 93-115.
138. SHAPIRO, B.A., YINGLING, Y.G., KASPRZAK, W., and BINDEWALD, E. (2007). Bridging the gap in RNA structure prediction. Curr. Opin. Struct. Biol. 17, 157-165. (Pubitemid 46575248)
139. SHU, D., HUANG, L., HOEPRICH, S., and GUO, P. (2003). Construction of phi29 DNA-packaging RNA (pRNA) monomers, dimers and trimers with variable sizes and shapes as potential parts for nano-devices. J. Nanosci. Nanotechnol. 3, 295-302. (Pubitemid 38597291)
140. SHU, D., MOLL, W.D., DENG, Z., MAO, C., and GUO, P. (2004). Bottom-up assembly of RNA arrays and superstructures as potential parts in nanotechnology. Nano Lett. 4, 1717-1723. (Pubitemid 39297452)
141. SHU, D., SHU, Y., HAQUE, F., ABDELMAWLA, S., and GUO, P. (2011a). Thermodynamically stable RNA threeway junctions as platform for constructing multifunctional nanoparticles for delivery of therapeutics. Nat. Nanotechnol. 6, 658-667.
142. SHU, Y., CINIER, M., FOX, S.R., BEN-JOHNATHAN, N., and GUO, P. (2011b). Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach. Mol. Ther. 19, 1304-1311.
143. SHU, Y., CINIER, M., SHU, D., and GUO, P. (2011c). Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells. Methods 54, 204-214.
144. SHU, Y., SHU, D., DIAO, Z., SHEN, G., and GUO, P. (2009). Fabrication of polyvalent therapeutic RNA nanoparticles for specific delivery of siRNA, ribozyme, and drugs to targeted cells for cancer therapy. IEEE NIH Life Sci. Syst. Appl. Workshop 2009, 9-12.
145. SHUKLA, G.C., HAQUE, F., TOR, Y., WILHELMSSON, L.M., TOULME, J.J., ISAMBERT, H., GUO, P., ROSSI, J.J., TENENBAUM, S.A., and SHAPIRO, B.A. (2011). A boost for the emerging field of RNA nanotechnology. ACS Nano. 5, 3405-3418.
146. SINGH, Y., MURAT, P., and DEFRANCQ, E. (2010). Recent developments in oligonucleotide conjugation. Chem. Soc. Rev. 39, 2054-2070.
147. SINGHA, K., NAMGUNG, R., and KIM, W.J. (2011). Polymers in small-interfering RNA delivery. Nucleic Acid Ther. 21, 133-147.
148. STUDNICKA, G.M., RAHN, G.M., CUMMINGS, I.W., and SALSER, W.A. (1978). Computer method for predicting the secondary structure of single-stranded RNA. Nucleic Acids Res. 5, 3365-3387. (Pubitemid 9017008)
149. SUGIMOTO, N., NAKANO, S., KATOH, M., MATSUMURA, A., NAKAMUTA, H., OHMICHI, T., YONEYAMA, M., and SASAKI, M. (1995). Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry 34, 11211-11216.
150. TROIBER, C., and WAGNER, E. (2011). Nucleic acid carriers based on precise polymer conjugates. Bioconjug. Chem. 22, 1737-1752.
151. TROTTIER, M., MAT-ARIP, Y., ZHANG, C., CHEN, C., SHENG, S., SHAO, Z., and GUO, P. (2000). Probing the structure of monomers and dimers of the bacterial virus phi29 hexamer RNA complex by chemical modification. RNA 6, 1257-1266.
152. TSAI, C.J., ZHENG, J., ALEMAN, C., and NUSSINOV, R. (2006). Structure by design: from single proteins and their building blocks to nanostructures. Trends Biotechnol. 24, 449-454. (Pubitemid 44374783)
153. TUCKER, B.J., and BREAKER, R.R. (2005). Riboswitches as versatile gene control elements. Curr. Opin. Struct. Biol. 15, 342-348. (Pubitemid 40826454)
154. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA ploymerase. Science 249, 505-510.
155. VAN ROSSENBERG, S.M., SLIEDREGT-BOL, K.M., MEEUWENOORD, N.J., VAN BERKEL, T.J., VAN BOOM, J.H., VAN DER MAREL, G.A., and BIESSEN, E.A. (2002). Targeted lysosome disruptive elements for improvement of parenchymal liver cellspecific gene delivery. J. Biol. Chem. 277, 45803-45810. (Pubitemid 35417558)
156. VARAMBALLY, S., DHANASEKARAN, S.M., ZHOU, M., BARRETTE, T.R., KUMAR-SINHA, C., SANDA, M.G., GHOSH, D., PIENTA, K.J., SEWALT, R.G., ET AL. (2002). The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629
157. VO-DINH, T. (2005). Protein nanotechnology: the new frontier in biosciences. Methods Mol. Biol. 300, 1-13.
158. WAGNER, C., EHRESMANN, C., EHRESMANN, B., and BRUNEL, C. (2004). Mechanism of dimerization of bicoid mRNA: initiation and stabilization. J. Biol. Chem. 279, 4560-4569. (Pubitemid 38199047)
159. WATTS, J.K., DELEAVEY, G.F., and DAMHA, M.J. (2008). Chemically modified siRNA: tools and applications. Drug Discov. Today 13, 842-855.
160. WESTHOF, E., MASQUIDA, B., and JAEGER, L. (1996). RNA tectonics: towards RNA design. Fold Des. 1, R78-R88. (Pubitemid 126748181)
161. WICHITWECHKARN, J., JOHNSON, D., and ANDERSON, D. (1992). Mutant prohead RNAs in the in vitro packaging of bacteriophage phi 29 DNA-gp3. J. Mol. Biol. 223, 991-998.
162. YE, X., HEMIDA, M., ZHANG, H.M., HANSON, P., YE, Q., and YANG, D. (2012). Current advances in Phi29 pRNA biology and its application in drug delivery. Wiley Interdiscip. Rev. RNA 3, 469-481.
163. YE, X., LIU, Z., HEMIDA, M.G., and YANG, D. (2011). Targeted delivery of mutant tolerant anti-coxsackievirus artificial microRNAs using folate conjugated bacteriophage Phi29 pRNA. PLoS One 6, e21215.
164. YINGLING, Y.G., and SHAPIRO, B.A. (2007). Computational design of an RNA hexagonal nanoring and an RNA nanotube. Nano Lett. 7, 2328-2334. (Pubitemid 47310128)
165. ZAUG, A.J., GRABOWSKI, P.J., and CECH, T.R. (1983). Autocatalytic cyclization of an excised intervening sequence RNA is a cleavage-ligation reaction. Nature 301, 578-583. (Pubitemid 13161526)
166. ZHANG, C.L., LEE, C-S., and GUO, P. (1994). The proximate 5¢ and 3¢ ends of the 120-base viral RNA (pRNA) are crucial for the packaging of bacteriophage f29 DNA. Virology 201, 77-85.
167. ZHANG, C.L., TELLINGHUISEN, T., and GUO, P. (1995a). Confirmation of the helical structure of the 5¢/3¢ termini of the essential DNA packaging pRNA of phage f29. RNA 1, 1041-1050.
168. ZHANG, C.L., TROTTIER, M., and GUO, P.X. (1995b). Circularly permuted viral pRNA active and specific in the packaging of bacteriophage Phi29 DNA. Virology 207, 442-451.
169. ZHANG, F., LEMIEUX, S., WU, X., ST.-ARNAUD, S., MCMURRAY, C.T., MAJOR, F., and ANDERSON, D. (1998). Function of hexameric RNA in packaging of bacteriophage phi29 DNA in vitro. Mol. Cell 2, 141-147. (Pubitemid 128378976)
170. ZHANG, H.M., SU, Y., GUO, S., YUAN, J., LIM, T., LIU, J., GUO, P., YANG, D. (2009). Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs. Antiviral Res. 83, 307-316.
171. ZHOU, J., SHU, Y., GUO, P., SMITH, D., and ROSSI, J. (2011). Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. Methods 54, 284-294.
172. ZHOU, J., LI, H., ZAIA, J., and ROSSI, J.J. (2008). Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol. Ther. 16, 1481-1489.
173. ZUKER, M. (1989). On finding all suboptimal foldings of an RNA molecule. Science 244, 48-52. (Pubitemid 19130742)